Dual action immunotherapy in CAR-T cells improves control of B-cell acute lymphoblastic leukemia progression
B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric leukemia cases. According to REDECAN, more than 400 new cases are estimated to be diagnosed in Spain ...
May 27, 2025
0
0